WallStSmart
OKYO

OKYO Pharma Ltd ADR

NASDAQ: OKYO · HEALTHCARE · BIOTECHNOLOGY

$1.56
+2.63% today

Updated 2026-04-30

Market cap
$82.92M
P/E ratio
P/S ratio
EPS (TTM)
$-0.11
Dividend yield
52W range
$1 – $3
Volume
0.1M

OKYO Pharma Ltd ADR (OKYO) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item200820092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$-513950.00$-226351.00$-878607.00$-1.31M$-4.67M$-3.82M$-3.45M$-1.42M$-650884.00$-651267.00$-1.59M$-1.99M$-1.20M$-1.60M$-5.47M$-7.70M$-9.49M$-1.81M
Capital expenditures$2.82M$717734.00$0.00$0.00$3.51M$7.18M$10.65M$2.76M$406045.00$375394.00$1014.00$1322.00$5031.00$6943.00$1669.00$5916.00$3.00$1208.00
Depreciation
Stock-based comp$2.39M$114608.00$180845.00$155878.00$825617.00$1.33M$1.41M$180277.00$99203.00$18372.00$4236.00$50533.00$36340.00$544387.00$1.72M$1.27M$1.12M$734989.00
Free cash flow$-3.33M$-944085.00$-878607.00$-1.31M$-8.18M$-11.00M$-14.10M$-4.18M$-1.06M$-1.03M$-1.60M$-1.99M$-1.21M$-1.61M$-5.47M$-7.70M$-9.49M$-1.81M
Investing cash flow
Financing cash flow
Dividends paid$40.74M
Share repurchases
Debt repayment
Net change in cash